Gene Symbol | Gene ID | Gene Info |
---|---|---|
Zfp282
|
ENSMUSG00000025821.9 | zinc finger protein 282 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_47877738_47878170 | Zfp282 | 298 | 0.848986 | -0.10 | 4.5e-01 | Click! |
chr6_47878218_47878369 | Zfp282 | 637 | 0.610001 | -0.07 | 6.1e-01 | Click! |
chr6_47877250_47877679 | Zfp282 | 192 | 0.912286 | 0.07 | 6.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_3236518_3237725 | 8.33 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr13_84448589_84449243 | 8.21 |
Gm26927 |
predicted gene, 26927 |
108803 |
0.07 |
chr9_41697271_41698297 | 6.54 |
Gm48784 |
predicted gene, 48784 |
22730 |
0.14 |
chr1_57218512_57218908 | 6.47 |
BC055402 |
cDNA sequence BC055402 |
3717 |
0.29 |
chr15_10655238_10655729 | 5.81 |
Gm10389 |
predicted gene 10389 |
55146 |
0.1 |
chr6_39242951_39243777 | 5.80 |
Gm43479 |
predicted gene 43479 |
3250 |
0.2 |
chr9_75683480_75683688 | 5.59 |
Scg3 |
secretogranin III |
3 |
0.97 |
chr16_63806441_63806811 | 5.41 |
Epha3 |
Eph receptor A3 |
56787 |
0.15 |
chr4_125545547_125545968 | 5.29 |
Mir692-2 |
microRNA 692-2 |
41008 |
0.15 |
chr1_173389908_173390099 | 4.97 |
Cadm3 |
cell adhesion molecule 3 |
22308 |
0.14 |
chr2_106083913_106084082 | 4.90 |
Gm29053 |
predicted gene 29053 |
43501 |
0.12 |
chr2_154421078_154421682 | 4.75 |
Snta1 |
syntrophin, acidic 1 |
13281 |
0.16 |
chr19_21787039_21787433 | 4.73 |
Cemip2 |
cell migration inducing hyaluronidase 2 |
8848 |
0.22 |
chr13_84285225_84285539 | 4.72 |
Gm46432 |
predicted gene, 46432 |
3566 |
0.21 |
chr1_25829046_25829236 | 4.54 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
370 |
0.73 |
chr15_52412947_52413184 | 4.53 |
Gm41322 |
predicted gene, 41322 |
32057 |
0.18 |
chr8_93917847_93918490 | 4.49 |
Gm24159 |
predicted gene, 24159 |
15768 |
0.16 |
chr9_103558749_103559112 | 4.48 |
4932413F04Rik |
RIKEN cDNA 4932413F04 gene |
1840 |
0.26 |
chr17_9726102_9726458 | 4.40 |
Gm34684 |
predicted gene, 34684 |
73 |
0.98 |
chr7_70118499_70118682 | 4.39 |
Gm35325 |
predicted gene, 35325 |
88845 |
0.08 |
chr12_67011393_67011748 | 4.39 |
Gm47989 |
predicted gene, 47989 |
69159 |
0.12 |
chr2_68346871_68347188 | 4.35 |
Stk39 |
serine/threonine kinase 39 |
19490 |
0.25 |
chr11_47640612_47640793 | 4.31 |
Sgcd |
sarcoglycan, delta (dystrophin-associated glycoprotein) |
3233 |
0.39 |
chr18_23038988_23039260 | 4.24 |
Nol4 |
nucleolar protein 4 |
185 |
0.97 |
chr4_142267860_142268115 | 4.20 |
Kazn |
kazrin, periplakin interacting protein |
28586 |
0.2 |
chr16_29894456_29894644 | 4.16 |
Gm26569 |
predicted gene, 26569 |
51966 |
0.11 |
chr2_109673868_109674486 | 4.12 |
Bdnf |
brain derived neurotrophic factor |
523 |
0.63 |
chr1_72823832_72824380 | 4.06 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
397 |
0.88 |
chr1_25179698_25179849 | 4.04 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
24950 |
0.16 |
chr6_91284798_91284980 | 4.01 |
Fbln2 |
fibulin 2 |
19010 |
0.17 |
chr15_18818564_18819019 | 4.00 |
C030047K22Rik |
RIKEN cDNA C030047K22 gene |
17 |
0.67 |
chr3_9751197_9751510 | 3.97 |
Gm16337 |
predicted gene 16337 |
6254 |
0.23 |
chr2_142163347_142163551 | 3.97 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
13158 |
0.31 |
chr4_129967696_129968003 | 3.91 |
1700003M07Rik |
RIKEN cDNA 1700003M07 gene |
7041 |
0.13 |
chr9_102039608_102039771 | 3.90 |
Gm37562 |
predicted gene, 37562 |
16868 |
0.18 |
chr2_101592129_101592615 | 3.89 |
B230118H07Rik |
RIKEN cDNA B230118H07 gene |
7438 |
0.19 |
chr3_88214893_88215221 | 3.88 |
Mir3093 |
microRNA 3093 |
114 |
0.72 |
chr13_55485759_55486053 | 3.86 |
Dbn1 |
drebrin 1 |
754 |
0.41 |
chr2_93199380_93200028 | 3.85 |
Trp53i11 |
transformation related protein 53 inducible protein 11 |
785 |
0.69 |
chr10_78787521_78787730 | 3.80 |
Slc1a6 |
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
6923 |
0.14 |
chr3_34646262_34646441 | 3.76 |
Gm42692 |
predicted gene 42692 |
3087 |
0.14 |
chr8_4677704_4678740 | 3.68 |
Gm7461 |
predicted gene 7461 |
143 |
0.62 |
chr10_23191223_23191374 | 3.66 |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
5692 |
0.26 |
chrX_163885761_163885973 | 3.65 |
Ap1s2 |
adaptor-related protein complex 1, sigma 2 subunit |
23150 |
0.2 |
chr3_33312360_33312511 | 3.61 |
Gm37031 |
predicted gene, 37031 |
29317 |
0.17 |
chr2_132029196_132030408 | 3.56 |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
199 |
0.94 |
chr12_84772482_84773778 | 3.56 |
Npc2 |
NPC intracellular cholesterol transporter 2 |
22 |
0.61 |
chr14_79882006_79882157 | 3.56 |
Gm6999 |
predicted gene 6999 |
8916 |
0.16 |
chr1_126686772_126687076 | 3.53 |
Nckap5 |
NCK-associated protein 5 |
51266 |
0.18 |
chr7_95688461_95688640 | 3.53 |
Gm44603 |
predicted gene 44603 |
213604 |
0.02 |
chr4_54331384_54331565 | 3.48 |
Gm12469 |
predicted gene 12469 |
95598 |
0.08 |
chr8_60028775_60028926 | 3.48 |
Gm26164 |
predicted gene, 26164 |
50740 |
0.18 |
chr3_8511467_8511691 | 3.43 |
Stmn2 |
stathmin-like 2 |
1993 |
0.36 |
chr3_85574245_85574500 | 3.43 |
Gatb |
glutamyl-tRNA(Gln) amidotransferase, subunit B |
177 |
0.76 |
chr13_54759243_54759407 | 3.42 |
Sncb |
synuclein, beta |
3742 |
0.14 |
chr11_80335618_80335993 | 3.39 |
Rhbdl3 |
rhomboid like 3 |
10598 |
0.18 |
chr10_84755143_84755591 | 3.37 |
Rfx4 |
regulatory factor X, 4 (influences HLA class II expression) |
695 |
0.74 |
chr3_26851001_26851285 | 3.37 |
Gm37659 |
predicted gene, 37659 |
161621 |
0.03 |
chr9_96725839_96726019 | 3.37 |
Zbtb38 |
zinc finger and BTB domain containing 38 |
3107 |
0.22 |
chr11_14350814_14351136 | 3.35 |
Gm12006 |
predicted gene 12006 |
136638 |
0.05 |
chr7_3390495_3390823 | 3.34 |
Cacng8 |
calcium channel, voltage-dependent, gamma subunit 8 |
24 |
0.89 |
chr18_19603967_19604152 | 3.30 |
Gm7720 |
predicted gene 7720 |
49099 |
0.19 |
chr9_92716909_92717060 | 3.29 |
4933400C23Rik |
RIKEN cDNA 4933400C23 gene |
472 |
0.84 |
chr13_79698330_79698512 | 3.21 |
Gm48471 |
predicted gene, 48471 |
139656 |
0.05 |
chr9_40537844_40538246 | 3.21 |
Gramd1b |
GRAM domain containing 1B |
6662 |
0.13 |
chr14_66343688_66343893 | 3.21 |
Stmn4 |
stathmin-like 4 |
506 |
0.75 |
chr2_65022121_65023287 | 3.20 |
Grb14 |
growth factor receptor bound protein 14 |
78 |
0.98 |
chr15_39816857_39817008 | 3.17 |
Gm16291 |
predicted gene 16291 |
19887 |
0.18 |
chr2_18799480_18799858 | 3.16 |
Carlr |
cardiac and apoptosis-related long non-coding RNA |
2149 |
0.3 |
chr11_20650348_20650541 | 3.13 |
Sertad2 |
SERTA domain containing 2 |
3289 |
0.27 |
chr13_99594252_99594622 | 3.11 |
Gm47158 |
predicted gene, 47158 |
32995 |
0.15 |
chr2_132030800_132030951 | 3.10 |
Rassf2 |
Ras association (RalGDS/AF-6) domain family member 2 |
617 |
0.72 |
chr15_10421430_10421775 | 3.10 |
Dnajc21 |
DnaJ heat shock protein family (Hsp40) member C21 |
28390 |
0.15 |
chr11_34348265_34348533 | 3.08 |
Insyn2b |
inhibitory synaptic factor family member 2B |
33577 |
0.16 |
chr2_93891393_93892295 | 3.07 |
Accsl |
1-aminocyclopropane-1-carboxylate synthase (non-functional)-like |
22687 |
0.14 |
chr15_76517232_76517738 | 3.04 |
Scrt1 |
scratch family zinc finger 1 |
4417 |
0.08 |
chr4_13408185_13408336 | 3.03 |
Gm11819 |
predicted gene 11819 |
36510 |
0.2 |
chr16_88112782_88112992 | 3.02 |
Grik1 |
glutamate receptor, ionotropic, kainate 1 |
56711 |
0.15 |
chr4_97583115_97583625 | 2.99 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
1226 |
0.54 |
chr13_36736583_36736914 | 2.99 |
Nrn1 |
neuritin 1 |
1617 |
0.34 |
chr10_17213050_17213244 | 2.98 |
Gm25382 |
predicted gene, 25382 |
96343 |
0.07 |
chr15_74162212_74162409 | 2.96 |
Gm15387 |
predicted gene 15387 |
67977 |
0.11 |
chr5_16294896_16295062 | 2.93 |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
31006 |
0.2 |
chr10_85673510_85673682 | 2.91 |
Btbd11 |
BTB (POZ) domain containing 11 |
19438 |
0.11 |
chr16_44632721_44633371 | 2.90 |
Boc |
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein |
74149 |
0.08 |
chr18_3807540_3807700 | 2.90 |
Gm23643 |
predicted gene, 23643 |
36816 |
0.18 |
chr3_108423057_108423282 | 2.90 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
7617 |
0.09 |
chr1_85089758_85090158 | 2.88 |
Gm10553 |
predicted gene 10553 |
9554 |
0.09 |
chr9_61549545_61549892 | 2.88 |
Gm34424 |
predicted gene, 34424 |
16303 |
0.23 |
chr3_83583502_83583680 | 2.88 |
1700028M03Rik |
RIKEN cDNA 1700028M03 gene |
9469 |
0.27 |
chr3_80331740_80331910 | 2.87 |
Gm37971 |
predicted gene, 37971 |
2770 |
0.35 |
chr1_132559167_132559406 | 2.87 |
Cntn2 |
contactin 2 |
16030 |
0.16 |
chr9_60266870_60267276 | 2.87 |
2010001M07Rik |
RIKEN cDNA 2010001M07 gene |
67069 |
0.11 |
chr7_79577344_79577537 | 2.86 |
Gm45168 |
predicted gene 45168 |
1628 |
0.22 |
chr9_56738591_56739084 | 2.85 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
30286 |
0.16 |
chr5_119916574_119916740 | 2.85 |
Gm43269 |
predicted gene 43269 |
1719 |
0.39 |
chr7_19083049_19083724 | 2.84 |
Dmpk |
dystrophia myotonica-protein kinase |
463 |
0.59 |
chr7_90426032_90426248 | 2.84 |
Ccdc89 |
coiled-coil domain containing 89 |
437 |
0.76 |
chr16_72610737_72610888 | 2.83 |
Robo1 |
roundabout guidance receptor 1 |
47112 |
0.2 |
chr2_181581056_181582098 | 2.82 |
Uckl1 |
uridine-cytidine kinase 1-like 1 |
49 |
0.9 |
chr5_44713283_44713692 | 2.82 |
Gm3364 |
predicted gene 3364 |
6597 |
0.15 |
chr16_5573047_5573245 | 2.81 |
n-R5s30 |
nuclear encoded rRNA 5S 30 |
248989 |
0.02 |
chr7_81372375_81372746 | 2.80 |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
75 |
0.97 |
chr8_91996683_91996834 | 2.77 |
Gm36843 |
predicted gene, 36843 |
836 |
0.56 |
chr12_45013262_45013696 | 2.76 |
Stxbp6 |
syntaxin binding protein 6 (amisyn) |
515 |
0.83 |
chr4_111691023_111691585 | 2.76 |
Spata6 |
spermatogenesis associated 6 |
28680 |
0.21 |
chr5_115404327_115404551 | 2.76 |
A930005G22Rik |
RIKEN cDNA A930005G22 gene |
18061 |
0.07 |
chr4_47521967_47522118 | 2.76 |
Sec61b |
Sec61 beta subunit |
47094 |
0.14 |
chr3_38892775_38893275 | 2.75 |
Fat4 |
FAT atypical cadherin 4 |
2083 |
0.36 |
chr2_65845289_65845528 | 2.73 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
359 |
0.89 |
chr10_26078004_26078490 | 2.72 |
Gm9767 |
predicted gene 9767 |
8 |
0.51 |
chr14_64587864_64588052 | 2.70 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
93 |
0.96 |
chr8_43356457_43356690 | 2.69 |
Gm22986 |
predicted gene, 22986 |
21402 |
0.21 |
chr12_21139716_21139867 | 2.68 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
27837 |
0.17 |
chrX_135993406_135993617 | 2.67 |
Arxes2 |
adipocyte-related X-chromosome expressed sequence 2 |
313 |
0.86 |
chr12_108959276_108959587 | 2.65 |
Gm47980 |
predicted gene, 47980 |
1481 |
0.33 |
chr18_60636784_60636935 | 2.64 |
Synpo |
synaptopodin |
7006 |
0.18 |
chr5_92263962_92264384 | 2.62 |
Naaa |
N-acylethanolamine acid amidase |
1391 |
0.27 |
chr13_21896611_21896849 | 2.62 |
Mir1983 |
microRNA 1983 |
319 |
0.72 |
chr1_25892841_25892992 | 2.61 |
Gm9884 |
predicted gene 9884 |
62259 |
0.08 |
chr11_61021780_61021931 | 2.60 |
Kcnj12 |
potassium inwardly-rectifying channel, subfamily J, member 12 |
709 |
0.67 |
chrX_135838588_135838853 | 2.59 |
Gprasp2 |
G protein-coupled receptor associated sorting protein 2 |
314 |
0.87 |
chr2_12419340_12419682 | 2.58 |
Mindy3 |
MINDY lysine 48 deubiquitinase 3 |
41 |
0.97 |
chr2_146710690_146711112 | 2.58 |
Gm14111 |
predicted gene 14111 |
44804 |
0.18 |
chr7_105639857_105640329 | 2.58 |
Timm10b |
translocase of inner mitochondrial membrane 10B |
37 |
0.62 |
chr15_88318097_88318435 | 2.57 |
4930445N06Rik |
RIKEN cDNA 4930445N06 gene |
2634 |
0.31 |
chr16_25016242_25016817 | 2.57 |
A230028O05Rik |
RIKEN cDNA A230028O05 gene |
43110 |
0.19 |
chr19_48205950_48206292 | 2.56 |
Sorcs3 |
sortilin-related VPS10 domain containing receptor 3 |
96 |
0.98 |
chr5_30587243_30587398 | 2.54 |
Kcnk3 |
potassium channel, subfamily K, member 3 |
850 |
0.43 |
chr13_83729640_83730023 | 2.54 |
Gm26803 |
predicted gene, 26803 |
249 |
0.86 |
chr12_88726248_88726514 | 2.53 |
Nrxn3 |
neurexin III |
700 |
0.74 |
chr15_25802308_25802503 | 2.53 |
Myo10 |
myosin X |
22215 |
0.18 |
chr12_77857429_77857616 | 2.52 |
Gm8219 |
predicted gene 8219 |
37940 |
0.18 |
chr7_112884297_112884484 | 2.52 |
Tead1 |
TEA domain family member 1 |
44756 |
0.15 |
chr13_89741226_89741547 | 2.51 |
Vcan |
versican |
858 |
0.59 |
chr12_89148877_89149466 | 2.51 |
Nrxn3 |
neurexin III |
43935 |
0.19 |
chr7_78579562_78579836 | 2.51 |
Gm9885 |
predicted gene 9885 |
869 |
0.42 |
chr2_142163598_142163798 | 2.50 |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
12909 |
0.31 |
chr10_54269510_54269661 | 2.48 |
Gm26177 |
predicted gene, 26177 |
41746 |
0.16 |
chr6_42323997_42324544 | 2.48 |
Fam131b |
family with sequence similarity 131, member B |
322 |
0.78 |
chr3_16431457_16431615 | 2.45 |
Ythdf3 |
YTH N6-methyladenosine RNA binding protein 3 |
248300 |
0.02 |
chr7_145173117_145173508 | 2.45 |
Gm45181 |
predicted gene 45181 |
10316 |
0.22 |
chr14_123626303_123627238 | 2.45 |
Nalcn |
sodium leak channel, non-selective |
106 |
0.98 |
chr3_67960318_67960469 | 2.45 |
Iqschfp |
Iqcj and Schip1 fusion protein |
68161 |
0.11 |
chr18_22798599_22798750 | 2.43 |
Nol4 |
nucleolar protein 4 |
29688 |
0.26 |
chrX_99449186_99449474 | 2.43 |
Gm14812 |
predicted gene 14812 |
5533 |
0.19 |
chr2_170807997_170808165 | 2.42 |
Dok5 |
docking protein 5 |
76274 |
0.11 |
chr3_39610074_39610225 | 2.42 |
Gm42781 |
predicted gene 42781 |
25910 |
0.19 |
chr18_81830833_81831208 | 2.38 |
Gm30454 |
predicted gene, 30454 |
18996 |
0.19 |
chr2_4401632_4401855 | 2.38 |
Frmd4a |
FERM domain containing 4A |
272 |
0.92 |
chrX_166344665_166345107 | 2.37 |
Gpm6b |
glycoprotein m6b |
44 |
0.98 |
chr1_119420165_119420366 | 2.35 |
Inhbb |
inhibin beta-B |
1983 |
0.33 |
chr2_50755830_50755981 | 2.34 |
Gm13484 |
predicted gene 13484 |
97838 |
0.08 |
chr10_117417772_117417942 | 2.34 |
Gm40770 |
predicted gene, 40770 |
3953 |
0.16 |
chr1_143145453_143145618 | 2.33 |
Gm5835 |
predicted gene 5835 |
50919 |
0.19 |
chr16_35613873_35614640 | 2.32 |
Gm5963 |
predicted pseudogene 5963 |
40700 |
0.13 |
chr6_148046855_148047684 | 2.32 |
Far2 |
fatty acyl CoA reductase 2 |
10 |
0.54 |
chr17_54201852_54202003 | 2.31 |
Gm37966 |
predicted gene, 37966 |
21586 |
0.21 |
chr15_58078836_58079038 | 2.30 |
Zhx1 |
zinc fingers and homeoboxes 1 |
2396 |
0.18 |
chr14_55853343_55853626 | 2.29 |
Nynrin |
NYN domain and retroviral integrase containing |
526 |
0.61 |
chr11_32161330_32161481 | 2.29 |
Gm12109 |
predicted gene 12109 |
23600 |
0.12 |
chr7_77812001_77812153 | 2.28 |
Gm23239 |
predicted gene, 23239 |
98243 |
0.09 |
chr1_172550258_172551042 | 2.28 |
4933439K11Rik |
RIKEN cDNA 4933439K11 gene |
19 |
0.96 |
chr16_54983981_54984151 | 2.27 |
Gm22977 |
predicted gene, 22977 |
11635 |
0.31 |
chr12_21140373_21140524 | 2.27 |
Asap2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
28494 |
0.17 |
chr3_137784274_137785017 | 2.26 |
Mir6380 |
microRNA 6380 |
1030 |
0.46 |
chr17_56473408_56473990 | 2.24 |
Ptprs |
protein tyrosine phosphatase, receptor type, S |
928 |
0.51 |
chr13_70096512_70096709 | 2.24 |
Gm47656 |
predicted gene, 47656 |
35052 |
0.14 |
chr9_118476912_118477183 | 2.24 |
Eomes |
eomesodermin |
1165 |
0.39 |
chr12_112721309_112722969 | 2.24 |
Cep170b |
centrosomal protein 170B |
35 |
0.95 |
chr6_134450673_134451117 | 2.23 |
Lrp6 |
low density lipoprotein receptor-related protein 6 |
14113 |
0.16 |
chr9_43506034_43506185 | 2.23 |
Gm36855 |
predicted gene, 36855 |
9723 |
0.19 |
chr7_49079077_49079259 | 2.21 |
Gm32849 |
predicted gene, 32849 |
5915 |
0.21 |
chr6_122562563_122562955 | 2.19 |
Gm16557 |
predicted gene 16557 |
714 |
0.48 |
chr2_64095648_64095799 | 2.19 |
Fign |
fidgetin |
2265 |
0.47 |
chr7_79500541_79500708 | 2.19 |
Mir9-3hg |
Mir9-3 host gene |
503 |
0.61 |
chr4_148159514_148160287 | 2.18 |
Fbxo44 |
F-box protein 44 |
23 |
0.92 |
chr19_24313171_24313351 | 2.18 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
4081 |
0.22 |
chr9_16353579_16353758 | 2.18 |
Fat3 |
FAT atypical cadherin 3 |
24563 |
0.26 |
chr10_92162409_92163019 | 2.17 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
47 |
0.98 |
chrX_12392204_12392355 | 2.16 |
Gm14635 |
predicted gene 14635 |
37283 |
0.18 |
chr3_105538540_105538834 | 2.15 |
Gm43847 |
predicted gene 43847 |
35780 |
0.16 |
chrX_157818323_157818501 | 2.15 |
Klhl34 |
kelch-like 34 |
23 |
0.98 |
chr3_154081729_154081880 | 2.14 |
Slc44a5 |
solute carrier family 44, member 5 |
34881 |
0.14 |
chr5_135957319_135957916 | 2.13 |
Ssc4d |
scavenger receptor cysteine rich family, 4 domains |
4654 |
0.13 |
chr2_37776412_37776715 | 2.12 |
Crb2 |
crumbs family member 2 |
314 |
0.91 |
chr10_75994691_75995012 | 2.11 |
Gm16220 |
predicted gene 16220 |
859 |
0.4 |
chr7_89628064_89628348 | 2.11 |
Me3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
4186 |
0.19 |
chr16_78707367_78707518 | 2.10 |
4930570E03Rik |
RIKEN cDNA 4930570E03 gene |
12408 |
0.22 |
chr11_33747522_33747673 | 2.10 |
Gm12120 |
predicted gene 12120 |
42047 |
0.15 |
chr5_81155797_81156194 | 2.10 |
Gm43594 |
predicted gene 43594 |
93254 |
0.09 |
chr18_84031319_84031526 | 2.10 |
Gm50421 |
predicted gene, 50421 |
43427 |
0.12 |
chrX_158924386_158924639 | 2.09 |
Gm5764 |
predicted gene 5764 |
91077 |
0.09 |
chr9_83146046_83146436 | 2.09 |
Hmgn3 |
high mobility group nucleosomal binding domain 3 |
229 |
0.56 |
chr19_59054407_59054843 | 2.08 |
Shtn1 |
shootin 1 |
16340 |
0.18 |
chr8_110275567_110275740 | 2.08 |
Gm26832 |
predicted gene, 26832 |
8191 |
0.19 |
chr6_127627623_127627869 | 2.08 |
Gm43634 |
predicted gene 43634 |
16694 |
0.18 |
chr1_104768116_104768267 | 2.07 |
Cdh20 |
cadherin 20 |
338 |
0.9 |
chr8_12400836_12401454 | 2.07 |
Gm25239 |
predicted gene, 25239 |
4742 |
0.15 |
chr15_27564815_27564966 | 2.07 |
Ank |
progressive ankylosis |
6557 |
0.17 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.4 | 4.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.9 | 2.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.9 | 2.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.7 | 3.0 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.7 | 3.0 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.7 | 2.9 | GO:0001927 | exocyst assembly(GO:0001927) |
0.7 | 4.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.7 | 2.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.7 | 2.6 | GO:0007412 | axon target recognition(GO:0007412) |
0.6 | 1.8 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.5 | 1.6 | GO:0030421 | defecation(GO:0030421) |
0.5 | 2.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 1.5 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.5 | 1.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.5 | 1.9 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.5 | 1.4 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.4 | 3.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 1.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 1.3 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.4 | 1.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.4 | 1.2 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.4 | 1.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.4 | 1.9 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 1.1 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 0.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.4 | 1.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.3 | 1.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 1.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.3 | 1.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 1.3 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.3 | 1.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.3 | 0.9 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.3 | 1.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.3 | 0.9 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.3 | 0.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 1.5 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.3 | 0.6 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.3 | 2.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.3 | 0.9 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.3 | 2.2 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.3 | 2.8 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.3 | 2.0 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.3 | 0.8 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.3 | 0.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.3 | 0.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.3 | 1.0 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.3 | 1.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.3 | 1.0 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.3 | 1.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.2 | 0.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.2 | 0.7 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 1.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.2 | 1.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.2 | 0.7 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.2 | 1.4 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 1.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.5 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.2 | 0.7 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 1.7 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 0.7 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.2 | 2.3 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.9 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.2 | 2.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 0.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.2 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
0.2 | 0.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 1.3 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 0.8 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.2 | 1.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.6 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.2 | 1.4 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.4 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 0.6 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.2 | 1.3 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 0.6 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 1.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 3.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.9 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.2 | 0.7 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.2 | 0.5 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.2 | 1.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.8 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 2.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 0.6 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.2 | 0.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 0.5 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.5 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.1 | 0.4 | GO:0033058 | directional locomotion(GO:0033058) |
0.1 | 0.3 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.1 | 0.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.1 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.8 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.8 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.4 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.1 | 0.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.7 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.1 | 0.3 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.1 | 1.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.4 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.3 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.1 | 0.3 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 1.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.9 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 1.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.7 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.2 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.4 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.6 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 0.5 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.1 | 0.2 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 0.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.3 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 1.0 | GO:0021756 | striatum development(GO:0021756) |
0.1 | 1.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.4 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 0.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.8 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.9 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 0.2 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.1 | 0.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.8 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.2 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.1 | 0.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.3 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.1 | 0.3 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 0.3 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.1 | 0.3 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.2 | GO:0006808 | regulation of nitrogen utilization(GO:0006808) |
0.1 | 0.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 8.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.6 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.8 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.1 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.1 | 0.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 2.8 | GO:0008347 | glial cell migration(GO:0008347) |
0.1 | 0.7 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 0.3 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 0.6 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.2 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 2.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.2 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.1 | 2.4 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.1 | 0.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.1 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 1.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.2 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.3 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.1 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 2.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.1 | 0.2 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.3 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.1 | 0.1 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.1 | 2.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.1 | 0.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.7 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 1.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.8 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 1.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.1 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.1 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.4 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.2 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.5 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 0.3 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.1 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.1 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 0.4 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.2 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.1 | 0.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.9 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.2 | GO:0019230 | proprioception(GO:0019230) |
0.1 | 0.6 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.2 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 0.1 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.1 | 1.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.1 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.1 | 0.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.1 | GO:0061551 | cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) |
0.1 | 0.3 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.3 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.5 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.1 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.1 | 0.4 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 1.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.2 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 1.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 1.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.1 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.1 | 0.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.4 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.7 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.1 | 0.3 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.0 | 0.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.0 | 0.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.0 | 0.1 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.0 | 0.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.0 | 0.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.0 | 0.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.3 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.0 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.0 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.0 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.0 | 0.9 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.0 | 0.5 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.0 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.0 | 0.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.3 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.0 | 0.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.0 | 0.2 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.1 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.0 | 0.5 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
0.0 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.2 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.0 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.0 | 0.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.0 | 0.4 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.1 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.0 | 1.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.1 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.0 | 0.4 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.0 | GO:1902966 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.0 | 0.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 | 0.0 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.0 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.0 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.0 | 0.7 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.0 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.0 | 0.2 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.0 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.0 | 0.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 0.1 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.2 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.0 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.0 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.8 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.2 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.0 | 0.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.0 | 0.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.3 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
0.0 | 0.0 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.0 | 1.0 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.1 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.0 | 0.1 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.0 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.5 | GO:0032835 | glomerulus development(GO:0032835) |
0.0 | 0.3 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.0 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.0 | 0.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.0 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.4 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.0 | GO:0072172 | mesonephric tubule formation(GO:0072172) |
0.0 | 0.4 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.0 | 0.2 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.0 | 0.0 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.0 | 0.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.0 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
0.0 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.1 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.0 | 0.0 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.0 | 0.0 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.0 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.0 | 0.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.0 | 0.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.0 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.0 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.1 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.0 | 0.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.0 | 0.0 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.0 | 0.3 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 0.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.1 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.0 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.0 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.0 | 0.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.2 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.6 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.0 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.1 | GO:0032196 | transposition(GO:0032196) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.0 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.0 | 0.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 0.1 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 0.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.0 | 0.0 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 | 0.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.2 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.0 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.0 | GO:0010288 | response to lead ion(GO:0010288) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.0 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.1 | GO:0051255 | mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.0 | GO:0015744 | succinate transport(GO:0015744) |
0.0 | 0.0 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.1 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.0 | 0.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.0 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.0 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.0 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.0 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.0 | 0.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.0 | 0.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.0 | 0.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.0 | 0.1 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.2 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.1 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.0 | 0.0 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.0 | 0.2 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.0 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.0 | 0.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.0 | 0.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.2 | GO:0042044 | fluid transport(GO:0042044) |
0.0 | 0.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 0.0 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.1 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.0 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.0 | 0.0 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.0 | 0.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.0 | 0.0 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.0 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.0 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.0 | 0.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.0 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.0 | 0.0 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.0 | 0.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.5 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.0 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.0 | 0.1 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.0 | 0.0 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.0 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.0 | 0.4 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.0 | 0.1 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.6 | 2.5 | GO:0044308 | axonal spine(GO:0044308) |
0.6 | 4.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 1.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.4 | 1.2 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.4 | 1.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.3 | 5.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.3 | 0.9 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.3 | 2.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 1.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 1.0 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.7 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 0.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 1.0 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 2.6 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 1.4 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.2 | 0.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.2 | 1.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 0.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 1.0 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 0.7 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 0.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.5 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 4.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.2 | 0.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 1.1 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 1.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 1.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.5 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 2.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 1.6 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 1.1 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 1.7 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.2 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 1.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 3.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.4 | GO:0097433 | dense body(GO:0097433) |
0.1 | 1.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 3.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 3.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 0.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 1.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 1.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.8 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.3 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.0 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.0 | 0.8 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.0 | 1.8 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 1.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.6 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.0 | 0.1 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.5 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.0 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 3.2 | GO:0070160 | occluding junction(GO:0070160) |
0.0 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 1.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 2.4 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.3 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 2.1 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 2.0 | GO:0098793 | presynapse(GO:0098793) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.2 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.0 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.2 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.2 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.0 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.7 | 3.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.6 | 2.5 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.6 | 1.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.4 | 1.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.4 | 1.3 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 3.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 1.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.3 | 1.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 1.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 1.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 2.6 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 1.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.3 | 0.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 0.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 1.7 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 1.2 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 2.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 0.8 | GO:0055100 | adiponectin binding(GO:0055100) |
0.2 | 0.7 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.2 | 2.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 1.7 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 2.6 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.2 | 1.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 1.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 1.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.2 | 1.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 2.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 1.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 1.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.2 | 1.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 0.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.7 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.2 | 1.9 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.2 | 0.6 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 2.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 0.5 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.1 | 1.2 | GO:0042299 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.4 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.1 | 1.0 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.4 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.5 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 1.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.4 | GO:0048045 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.1 | 0.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 2.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 2.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 1.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.3 | GO:0035939 | microsatellite binding(GO:0035939) |
0.1 | 2.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 4.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.3 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 0.1 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 0.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 2.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 1.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.4 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.1 | 2.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 0.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 0.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.2 | GO:0048763 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
0.1 | 1.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 2.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.2 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.4 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
0.1 | 0.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 1.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 1.0 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 1.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.1 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 1.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 0.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 1.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.2 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 1.2 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 3.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.1 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.2 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 0.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 0.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.3 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 1.0 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.2 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.7 | GO:0018748 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 1.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.9 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 1.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 1.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.0 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 1.6 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.3 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.0 | 0.4 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.1 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.0 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 1.1 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.1 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 2.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.1 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.0 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 0.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.0 | 0.0 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.1 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.0 | 1.0 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.1 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.0 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.7 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.3 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.0 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.5 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.5 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 2.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.0 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.0 | GO:0035877 | death effector domain binding(GO:0035877) |
0.0 | 0.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.0 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 1.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 2.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.1 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 0.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 2.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 3.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 4.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 2.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 1.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.2 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 1.5 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.1 | 0.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 1.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 2.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 0.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.6 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.7 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.1 | 0.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.5 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 0.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 1.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 1.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 1.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.2 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.0 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.0 | 0.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.0 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 0.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |